Cargando…
Use of genetically modified bacteria for drug delivery in humans: Revisiting the safety aspect
The use of live, genetically modified bacteria as delivery vehicles for biologics is of considerable interest scientifically and has attracted significant commercial investment. We have pioneered the use of the commensal gut bacterium Bacteroides ovatus for the oral delivery of therapeutics to the g...
Autores principales: | Wegmann, Udo, Carvalho, Ana Lucia, Stocks, Martin, Carding, Simon R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442108/ https://www.ncbi.nlm.nih.gov/pubmed/28536456 http://dx.doi.org/10.1038/s41598-017-02591-6 |
Ejemplares similares
-
Safety Aspects of Genetically Modified Lactic Acid Bacteria
por: Plavec, Tina Vida, et al.
Publicado: (2020) -
Complete Genome Sequence of Bacteroides ovatus V975
por: Wegmann, Udo, et al.
Publicado: (2016) -
Bioengineering commensal bacteria-derived outer membrane vesicles for
delivery of biologics to the gastrointestinal and respiratory tract
por: Carvalho, Ana L., et al.
Publicado: (2019) -
A Novel Tightly Regulated Gene Expression System for the Human Intestinal Symbiont Bacteroides thetaiotaomicron
por: Horn, Nikki, et al.
Publicado: (2016) -
The Proteome of Extracellular Vesicles Produced by the Human Gut Bacteria Bacteroides thetaiotaomicron
In Vivo Is Influenced by Environmental and Host-Derived Factors
por: Stentz, Régis, et al.
Publicado: (2022)